Epalrestat
Epalrestat CAS Nr.: 82159-09-9
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestat gëtt benotzt fir periphere Neuropathie (Taubheit, Schmerz), Vibratiounsparästhesie a kardiologesch Anomalie verbonne mat Diabetis ze vermeiden, ze verbesseren an ze behandelen. SPECIFIKATIOUN
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestat gëtt benotzt fir periphere Neuropathie (Taubheit, Schmerz), Vibratiounsparästhesie a kardiologesch Anomalie verbonne mat Diabetis ze vermeiden, ze verbesseren an ze behandelen. SPECIFIKATIOUN
| P roduct Numm | Epalrestat |
| CAS | 82159-09-9 |
| MF: | C15H13NO3S2 |
| MW: | 319.4 |
Schreift Äre Message hei a schéckt en un eis
